TCTR20210929002招募中3 期
Efficacy of Ivermectin in Prevention and Treatment of COVID-19: A Randomized-Controlled Study
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1.Patients with respiratory tract symptoms or fever, or asymptomatic and contact with confirmed COVID-19 at outpatients clinic
- •2.Performed nasopharyngeal swab for PCR-COVID on the enrollment date
- •3. Available for telephone interview
- •4.Able to sign written informed consent
排除标准
- •1. Previous COVID-19 infection within 90 days before enrollment
- •2. Pregnancy and/or lactation
- •3. Allergy to Ivermectin or drugs with gamma-aminobutyric acid (GABA) potentiating activity and/or altered p-glycoprotein transport system
研究者
相似试验
已完成
1 期
Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adultsMalariaPACTR201908520097051Centre de Recherches Medicales de Lambarene49
尚未招募
3 期
Prophylactic Ivermectin in COVID 19 ContactsCTRI/2020/08/027282Department of Community Medicine
招募中
3 期
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375
尚未招募
4 期
Ivermectin prophylaxis for Covid-19 Infection in Health care PersonnelCTRI/2021/03/031665AIIMS Rishikesh
已完成
2 期
Evaluating the effect of Ivermectin on covid 19 patientsCOVID 19.Corona virus infection, unspecifiedU07.1IRCT20200404046937N4Ahvaz University of Medical Sciences60